The Indiana House of Representatives advanced State Rep. Jennifer Meltzer's bill classifying xylazine, an animal tranquilizer making its way into street drugs, as a controlled substance.
Under Meltzer's legislation, a prescription would be required to possess xylazine, a large animal sedative known as "tranq," or an individual could face criminal penalties.
"Xylazine is being mixed with illicit drugs like heroin, and users can experience horrible side effects and potentially long-lasting consequences," said Meltzer (R-Shelbyville), vice chair of the House Courts and Criminal Code Committee. "Our goal is to give law enforcement a new tool to get this drug off our streets and hold bad actors accountable while also protecting the drug's veterinary uses."
House Bill 1203 makes possession of xylazine a Class A misdemeanour or a Level 6 felony if the person has a prior unrelated conviction. Exceptions would include federally approved people who dispense, prescribe, or administer a drug containing xylazine, those who manufacture, distribute, or use xylazine as an active ingredient for animal drugs; licenced pharmacists and veterinarians; and other federally approved persons.
According to the National Institute on Drug Abuse, xylazine is a central nervous system depressant that can cause drowsiness and amnesia, and slow breathing, heart rate and blood pressure to dangerously low levels. Repeated xylazine use is also associated with skin ulcers, abscesses and related complications. Since xylazine is not an opiate, overdose reversal medication like Narcan is less effective, increasing the chance of permanent injury or death.
Additionally, Meltzer co-authored a bill to legalize drug testing strips also advanced out of the House of Representatives. House Bill 1053 would remove the tests from being categorized as drug paraphernalia. For example, Meltzer said drug users could use the strips to test any substance for xylazine, fentanyl or other potentially fatal substances.
During the 2023 legislative session, Meltzer authored a new law that tasks coroners with testing for any trace of xylazine in suspected and known drug overdose deaths. This includes if the victim was resistant to reversal medications. She said the data gathered from these reports will help Indiana get a clearer picture of the drug's presence in the state and begin to form an action plan.
House Bill 1203 now heads to the Indiana Senate for consideration. To learn more about the bill and other legislation, visit iga.in.gov.
Bost Veterans Act passes in U.S. House of Representatives
Health emergency declared in Knox County
Search continues for southwestern Indiana murder suspect
Lawrenceville moving forward toward old LHS demolition
Lawrence County time capsule to be opened
Lawrence County honors its' servicemen and women on Veterans Day
Illinois State Police to conduct holiday safety patrols
LCMH adds new team member
Toyota Princeton plant to produce new vehicle
Illinois to get additional federal healthcare funding
Prep your vehicle for winter weather
Expanded opportunities for incarcerated Hoosiers through 10-year Ivy Tech partnership
Southwestern Indiana fatal accident victim identified
Bridgeport to look at property ordinance revision
Conservation officers remind hunters to prioritize safety during deer season
Knox County caucus set to replace Streeter
Unit 20 Board to replace football field turf
